We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,259.00
Bid: 3,259.00
Ask: 3,261.00
Change: 18.00 (0.56%)
Spread: 2.00 (0.061%)
Open: 3,265.00
High: 3,294.00
Low: 3,253.00
Prev. Close: 3,241.00
EXPN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Experian plc Trading update, Third quarter

17 Jan 2020 07:00

RNS Number : 0951A
Experian plc
17 January 2020
 

news release

 

 

Trading update, Third quarter 

17 January 2020Experian, the global information services company, today issues an update on trading for the three months ended 31 December 2019.

 

Commenting on the performance, Brian Cassin, Chief Executive Officer, said:

 

"We delivered another quarter of good growth as we execute on our strategy of innovation-led growth. Total revenue growth in Q3 was 9% and organic revenue growth was 7%, both at constant exchange rates. At actual exchange rates total growth was 7%. Overall the performance was in line with our expectations and our guidance for the full year is unchanged." 

 

% change in revenue from ongoing activities year-on-year for the three months ended 31 December 2019

 

Ongoing activities only

Total revenue growth %

Total revenue growth %

Organic revenue growth %

 

At actual

exchange rates1

At constant exchange rates

At constant exchange rates

North America

11

11

10

Latin America

10

19

18

UK and Ireland

(3)

(3)

(3)

EMEA/Asia Pacific

(4)

(1)

(13)

Experian

7

9

7

1 Experian reports in US dollars.

 

% change in organic revenue year-on-year for the three months ended 31 December 2019

Organic revenue growth1

Data

Decisioning

B2B2

Consumer Services

Experian

 

 

 

 

 

 

North America

12

8

11

7

10

Latin America

17

25

18

n/a

18

UK and Ireland

1

(12)

(4)

1

(3)

EMEA/Asia Pacific

10

(29)

(13)

n/a

(13)

Experian

12

(3)

7

6

7

1 Ongoing activities only, at constant exchange rates.

2 B2B = Business-to-Business segment consists of Data and Decisioning business sub-divisions.

 

North America

 

We delivered strong growth in North America, where organic revenue increased by 10%, notwithstanding the effect of one-off third-party breach support revenue in the prior year. Total revenue growth was 11%, reflecting acquisition contributions from AllClear ID, MyHealthDirect and AutoID.

 

B2B performed well with organic growth of 11%. In Data, there was growth across all core areas of activity, reflecting strength in credit data volumes, mortgage and contributions from new products. There was further progress in the roll-out of Ascend, as we launched the new Ascend Data Services module, and we continue to secure significant synergies from non-traditional credit data assets (Clarity Services). Decisioning also performed well, reflecting strength in fraud and identity management volumes, and there was further strong progress in health.

 

Consumer Services performed well, with organic revenue up 7%, even as we lapped one-off data breach support revenue in the prior year comparable. Experian Boost has continued to perform very well, and we have further expanded our free membership base. We now have c. 27m US consumers on our free membership platform, and 2.4 million US consumers have connected their accounts to Experian Boost. This has led to growth across our direct-to-consumer ecosystem, including triple-digit growth in CreditMatch, our credit comparison offer.

 

Latin America

 

Latin America had a particularly strong quarter, with organic revenue growth of 18% at constant exchange rates, including a stand-out performance in Brazil. Total revenue growth at constant exchange rate was 19%, reflecting the first-time contribution from the acquisition of Sentinel Peru. Organic growth in Brazil reflected excellent performances across the business, including growth in consumer information, business information and Decisioning. We also saw a strong contribution from our consumer activities, following a highly successful credit fair for Limpa Nome, our debt resolution service, and as we secure further traction for online credit comparison services through our eCred offer. We now have 42 million free consumer memberships in Brazil. There was also further progress in Spanish Latin America, with another good performance in Colombia.

 

We remain on track for the introduction of positive data in Brazil and expect commercial offers including positive data to be available from the end of this month.

 

UK and Ireland

 

In the UK and Ireland, both total and organic revenue declined (3)% at constant exchange rates.

 

Organic revenue for Data grew by 1%, as growth in consumer and business information offset weakness in targeting and automotive. We continue to make encouraging progress in digital services, including strength in eligibility services, and we see good prospects for our newer propositions, including trended data, as well as for affordability services through our open-data platforms. Decisioning was weak with an organic revenue decline of (12)% as we continue to experience longer sales cycles and deferral of decision-making by clients for large software implementations and data quality services. Combined, this led to a (4)% decline in organic revenue for B2B overall.

 

Consumer Services delivered organic revenue growth of 1%. Free memberships reached 7 million, contributing to very strong growth in CreditMatcher, our comparison service, which offset ongoing decline in legacy credit monitoring subscription revenue.

 

EMEA/Asia Pacific

 

At constant exchange rates, total revenue across EMEA/Asia Pacific declined by (1)%, while organic revenue declined by (13)%. The difference related to the contribution from the acquisition of Compuscan and other smaller acquisitions. Data performed strongly, with organic revenue growth of 10%, driven by strength in India, Southeast Asia and the Nordics. This was offset by a decline in Decisioning, with organic revenue down (29)% as we lapped strong prior comparables and due to some phasing of contract wins between quarters. Across EMEA/Asia Pacific, we've seen growing pipelines for affordability, decisioning software and marketplace offers and we expect a return to growth in Q4 FY20.

 

Future events

 

Experian will release results for the year ending 31 March 2020 on Wednesday 20 May 2020.

 

Contact:

Experian

Nadia Ridout-Jamieson Investor queries +44 (0)20 3042 4215

Gerry Tschopp Media queries +1 949 677 3377

 

Finsbury

Rollo Head +44 (0)20 7251 3801

Jenny Davey

 

This announcement is available on the Experian website at www.experianplc.com.

 

All financial information in this trading update is based on unaudited management accounts. Certain statements made in this trading update are forward-looking statements. Such statements are based on current expectations and are subject to a number of risks and uncertainties that could cause actual events or results to differ materially from any expected future events or results referred to in these forward-looking statements.

 

Neither the content of the Company's website, nor the content of any website accessible from hyperlinks on the Company's website (or any other website), is incorporated into, or forms part of, this announcement.

 

About Experian

Experian is the world's leading global information services company. During life's big moments - from buying a home or a car, to sending a child to college, to growing a business by connecting with new customers - we empower consumers and our clients to manage their data with confidence. We help individuals to take financial control and access financial services, businesses to make smarter decisions and thrive, lenders to lend more responsibly, and organisations to prevent identity fraud and crime.

 

We have 17,200 people operating across 44 countries and every day we're investing in new technologies, talented people and innovation to help all our clients maximise every opportunity. We are listed on the London Stock Exchange (EXPN) and are a constituent of the FTSE 100 Index.

 

Learn more at www.experianplc.com or visit our global content hub at our global news blog for the latest news and insights from the Group.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFSALEIRLII
Date   Source Headline
22nd Apr 20245:34 pmRNSTransaction in Own Shares
19th Apr 20245:42 pmRNSTransaction in Own Shares
18th Apr 20245:41 pmRNSTransaction in Own Shares
17th Apr 20245:21 pmRNSTransaction in Own Shares
16th Apr 20245:40 pmRNSTransaction in Own Shares
15th Apr 20245:39 pmRNSTransaction in Own Shares
12th Apr 20246:00 pmRNSTransaction in Own Shares
11th Apr 20245:42 pmRNSTransaction in Own Shares
10th Apr 20245:44 pmRNSTransaction in Own Shares
10th Apr 20249:45 amRNSAdditional Listing
9th Apr 20246:04 pmRNSTransaction in Own Shares
8th Apr 20246:14 pmRNSTransaction in Own Shares
8th Apr 20247:54 amRNSShare repurchase programme
4th Apr 20246:00 pmRNSExperian to acquire Illion in ANZ
3rd Apr 20249:30 amRNSDirector/PDMR Shareholding
28th Mar 202411:05 amRNSTotal Voting Rights
21st Mar 202412:15 pmRNSBlock listing Interim Review
20th Mar 20248:47 amRNSAdditional Listing
14th Mar 20242:08 pmRNSAdditional Listing
6th Mar 20249:15 amRNSAdditional Listing
4th Mar 202411:45 amRNSExperian signs new Revolving Credit Facility
29th Feb 202411:30 amRNSTotal Voting Rights
28th Feb 202410:15 amRNSDirector/PDMR Shareholding
28th Feb 20249:15 amRNSAdditional Listing
21st Feb 20249:15 amRNSAdditional Listing
14th Feb 20249:15 amRNSAdditional Listing
7th Feb 20249:14 amRNSAdditional Listing
6th Feb 20243:47 pmRNSDirector/PDMR Shareholding
31st Jan 202410:00 amRNSTotal Voting Rights
31st Jan 20249:20 amRNSAdditional Listing
24th Jan 20249:47 amRNSAdditional Listing
17th Jan 202412:44 pmRNSDirector/PDMR Shareholding
17th Jan 20249:44 amRNSAdditional Listing
16th Jan 20247:00 amRNSExperian Q3 FY24 trading update
12th Jan 20245:44 pmRNSFirst Interim Dividend
10th Jan 202410:55 amRNSAdditional Listing
3rd Jan 20249:02 amRNSAdditional Listing
29th Dec 202310:03 amRNSTotal Voting Rights
15th Dec 20239:32 amRNSElections for first interim dividend
13th Dec 20239:31 amRNSAdditional Listing
6th Dec 20239:14 amRNSAdditional Listing
30th Nov 202312:14 pmRNSTotal Voting Rights
29th Nov 20239:43 amRNSAdditional Listing
22nd Nov 20239:25 amRNSAdditional Listing
15th Nov 20237:00 amRNSHalf-year Report
10th Nov 20239:00 amRNSDirector Declaration
31st Oct 20235:04 pmRNSTransaction in Own Shares
31st Oct 202312:22 pmRNSTotal Voting Rights
30th Oct 20235:13 pmRNSTransaction in Own Shares
27th Oct 20235:32 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.